Anika Therapeutics
Update in progressANIK (NasdaqGS)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Anika Therapeutics, Inc. is a joint preservation company focused on early intervention orthopedics in the U.S., Europe, and abroad. It offers HA-based OA pain management products such as Monovisc, Orthovisc, and Cingal, plus regenerative solutions like an HA scaffold with fixation, Hyalofast, Tactoset, and Integrity. The portfolio also includes Hyvisc and Hyalobarrier, ophthalmic products, Anikavisc, and Nuvisc. Founded in 1983, it is headquartered in Bedford, Massachusetts.
Company score
- Sentiment
- -0.10
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.11
- Governance
- 0.15
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.06
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.02
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!